Acute Lymphoblastic Leukemia, Pediatric Recruiting Phase 1 / 2 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0081765 (Acute Lymphoblastic Leukemia, Pediatric)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03676504Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CARTreatment